-
1
-
-
0030973344
-
Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies
-
Adkins JC, Peters DH, Markham A (1997) Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies. Drugs 53:1005-1037
-
(1997)
Drugs
, vol.53
, pp. 1005-1037
-
-
Adkins, J.C.1
Peters, D.H.2
Markham, A.3
-
3
-
-
2342467469
-
Prospective strategies to enforce selectively cell death in cancer cells
-
Blagosklonny MV (2004) Prospective strategies to enforce selectively cell death in cancer cells. Oncogene 23:2967-2975
-
(2004)
Oncogene
, vol.23
, pp. 2967-2975
-
-
Blagosklonny, M.V.1
-
4
-
-
2042454565
-
Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells
-
Bornhauser M, Storer B, Slattery JT, Appelbaum FR, Deeg HJ, Hansen J, Martin PJ, McDonald GB, Nichols WG, Radich J, Woolfrey A, Jenke A, Schleyer E, Thiede C, Ehninger G, Anasetti C (2003) Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells. Blood 102:820-826
-
(2003)
Blood
, vol.102
, pp. 820-826
-
-
Bornhauser, M.1
Storer, B.2
Slattery, J.T.3
Appelbaum, F.R.4
Deeg, H.J.5
Hansen, J.6
Martin, P.J.7
McDonald, G.B.8
Nichols, W.G.9
Radich, J.10
Woolfrey, A.11
Jenke, A.12
Schleyer, E.13
Thiede, C.14
Ehninger, G.15
Anasetti, C.16
-
5
-
-
0037099675
-
Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells
-
Bröker LE, Huisman C, Ferreira CG, Rodriguez JA, Kruyt FA, Giaccone G (2002) Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells. Cancer Res 62:4081-4088
-
(2002)
Cancer Res
, vol.62
, pp. 4081-4088
-
-
Bröker, L.E.1
Huisman, C.2
Ferreira, C.G.3
Rodriguez, J.A.4
Kruyt, F.A.5
Giaccone, G.6
-
6
-
-
0037039381
-
Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
-
Chang BD, Swift ME, Shen M, Fang J, Broude EV, Roninson IB (2002) Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci USA 99:389-394
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 389-394
-
-
Chang, B.D.1
Swift, M.E.2
Shen, M.3
Fang, J.4
Broude, E.V.5
Roninson, I.B.6
-
7
-
-
0035351214
-
In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine
-
Chow KU, Boehrer S, Geduldig K, Krapohl A, Hoelzer D, Mitrou PS, Weidmann E (2001) In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine. Haematologica 86:485-493
-
(2001)
Haematologica
, vol.86
, pp. 485-493
-
-
Chow, K.U.1
Boehrer, S.2
Geduldig, K.3
Krapohl, A.4
Hoelzer, D.5
Mitrou, P.S.6
Weidmann, E.7
-
8
-
-
0036334046
-
Bendamustine in the treatment of hematologic malignancies. Introduction
-
Diehl V, Cheson BD (2002) Bendamustine in the treatment of hematologic malignancies. Introduction. Semin Oncol 29:1-3
-
(2002)
Semin Oncol
, vol.29
, pp. 1-3
-
-
Diehl, V.1
Cheson, B.D.2
-
9
-
-
0032949451
-
Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia
-
Foran JM, Oscier D, Orchard J, Johnson SA, Tighe M, Cullen MH, de Takats PG, Kraus C, Klein M, Lister TA (1999) Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia. J Clin Oncol 17:1574-1579
-
(1999)
J Clin Oncol
, vol.17
, pp. 1574-1579
-
-
Foran, J.M.1
Oscier, D.2
Orchard, J.3
Johnson, S.A.4
Tighe, M.5
Cullen, M.H.6
De Takats, P.G.7
Kraus, C.8
Klein, M.9
Lister, T.A.10
-
10
-
-
0036340122
-
Metabolism and mechanisms of action of bendamustine: Rationales for combination therapies
-
Gandhi V (2002) Metabolism and mechanisms of action of bendamustine: rationales for combination therapies. Semin Oncol 29:4-11
-
(2002)
Semin Oncol
, vol.29
, pp. 4-11
-
-
Gandhi, V.1
-
11
-
-
0036204648
-
Cellular and clinical pharmacology of fludarabine
-
Gandhi V, Plunkett W (2002) Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet 41:93-103
-
(2002)
Clin Pharmacokinet
, vol.41
, pp. 93-103
-
-
Gandhi, V.1
Plunkett, W.2
-
12
-
-
0027202081
-
Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapy
-
Gandhi V, Kemena A, Keating MJ, Plunkett W (1993) Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapy. Leuk Lymphoma 10:49-56
-
(1993)
Leuk Lymphoma
, vol.10
, pp. 49-56
-
-
Gandhi, V.1
Kemena, A.2
Keating, M.J.3
Plunkett, W.4
-
13
-
-
33645744086
-
Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2
-
Godal R, Keilholz U, Uharek L, Letsch A, Asemissen AM, Busse A, Na IK, Thiel E, Scheibenbogen C (2006) Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2. Blood 107:3205-3211
-
(2006)
Blood
, vol.107
, pp. 3205-3211
-
-
Godal, R.1
Keilholz, U.2
Uharek, L.3
Letsch, A.4
Asemissen, A.M.5
Busse, A.6
Na, I.K.7
Thiel, E.8
Scheibenbogen, C.9
-
14
-
-
34247177620
-
A mathematical approach to study combined effects of toxicants in vitro: Evaluation of the Bliss independence criterion and the Loewe additivity model
-
Goldoni M, Johansson C (2007) A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model. Toxicol In Vitro 21:759-769
-
(2007)
Toxicol in Vitro
, vol.21
, pp. 759-769
-
-
Goldoni, M.1
Johansson, C.2
-
15
-
-
0142227045
-
In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells
-
Gómez SG, Bueren JA, Faircloth GT, Jimeno J, Albella B (2003) In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells. Exp Hematol 31:1104-1111
-
(2003)
Exp Hematol
, vol.31
, pp. 1104-1111
-
-
Gómez, S.G.1
Bueren, J.A.2
Faircloth, G.T.3
Jimeno, J.4
Albella, B.5
-
16
-
-
20144386351
-
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: Report of a phase II trial
-
Gupta S, Zhou P, Hassoun H, Kewalramani T, Reich L, Costello S, Drake L, Klimek V, Dhodapkar M, Teruya-Feldstein J, Hedvat C, Kalakonda N, Fleisher M, Filippa D, Qin J, Nimer SD, Comenzo RL (2005) Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial. Bone Marrow Transplant 35:441-447
-
(2005)
Bone Marrow Transplant
, vol.35
, pp. 441-447
-
-
Gupta, S.1
Zhou, P.2
Hassoun, H.3
Kewalramani, T.4
Reich, L.5
Costello, S.6
Drake, L.7
Klimek, V.8
Dhodapkar, M.9
Teruya-Feldstein, J.10
Hedvat, C.11
Kalakonda, N.12
Fleisher, M.13
Filippa, D.14
Qin, J.15
Nimer, S.D.16
Comenzo, R.L.17
-
17
-
-
33645730985
-
Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma
-
Hagenbeek A, Eghbali H, Monfardini S, Vitolo U, Hoskin PJ, de Wolf- Peeters C, MacLennan K, Staab-Renner E, Kalmus J, Schott A, Teodorovic I, Negrouk A, van Glabbeke M, Marcus R (2006) Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma. J Clin Oncol 24:1590-1596
-
(2006)
J Clin Oncol
, vol.24
, pp. 1590-1596
-
-
Hagenbeek, A.1
Eghbali, H.2
Monfardini, S.3
Vitolo, U.4
Hoskin, P.J.5
De Wolf-Peeters, C.6
MacLennan, K.7
Staab-Renner, E.8
Kalmus, J.9
Schott, A.10
Teodorovic, I.11
Negrouk, A.12
Van Glabbeke, M.13
Marcus, R.14
-
18
-
-
39349098418
-
Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: A nationwide analysis
-
Jantunen E, Itälä M, Siitonen T, Kuittinen T, Heiskanen J, Koivunen E, Juvonen E, Silvennoinen R, Nousiainen T, Koistinen P, Volin L, Remes K (2008) Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis. Bone Marrow Transplant 41:239-244
-
(2008)
Bone Marrow Transplant
, vol.41
, pp. 239-244
-
-
Jantunen, E.1
Itälä, M.2
Siitonen, T.3
Kuittinen, T.4
Heiskanen, J.5
Koivunen, E.6
Juvonen, E.7
Silvennoinen, R.8
Nousiainen, T.9
Koistinen, P.10
Volin, L.11
Remes, K.12
-
19
-
-
3442880514
-
Fludarabine and bendamustine in refractory and relapsed indolent lymphoma-a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO)
-
Koenigsmann M, Knauf W, Herold M, Pasold R, Muller G, Eschenburg H, Kahl C, Lakner V, Assmann M, Jentsch-Ullrich K, Mohren M, Bartsch R, Franke A (2004) Fludarabine and bendamustine in refractory and relapsed indolent lymphoma-a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO). Leuk Lymphoma 45:1821-1827
-
(2004)
Leuk Lymphoma
, vol.45
, pp. 1821-1827
-
-
Koenigsmann, M.1
Knauf, W.2
Herold, M.3
Pasold, R.4
Muller, G.5
Eschenburg, H.6
Kahl, C.7
Lakner, V.8
Assmann, M.9
Jentsch-Ullrich, K.10
Mohren, M.11
Bartsch, R.12
Franke, A.13
-
21
-
-
0035158419
-
Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma
-
Perea G, Sureda A, Martino R, Altes A, Martinez C, Cabezudo E, Amill B, Martin-Henao GA, Gonzalez Y, Munoz L, Peyret M, Brunet S, Sierra J (2001) Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma. Ann Hematol 80:592-597
-
(2001)
Ann Hematol
, vol.80
, pp. 592-597
-
-
Perea, G.1
Sureda, A.2
Martino, R.3
Altes, A.4
Martinez, C.5
Cabezudo, E.6
Amill, B.7
Martin-Henao, G.A.8
Gonzalez, Y.9
Munoz, L.10
Peyret, M.11
Brunet, S.12
Sierra, J.13
-
22
-
-
31344443373
-
Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and prednisone-a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)
-
Pönisch W, Mitrou PS, Merkle K, Herold M, Assmann M, Wilhelm G, Dachselt K, Richter P, Schirmer V, Schulze A, Subert R, Harksel B, Grobe N, Stelzer E, Schulze M, Bittrich A, Freund M, Pasold R, Friedrich T, Helbig W, Niederwieser D, East German Study Group of Hematology, Oncology (OSHO) (2006) Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and prednisone-a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO). J Cancer Res Clin Oncol 132:205-212
-
(2006)
J Cancer Res Clin Oncol
, vol.132
, pp. 205-212
-
-
Pönisch, W.1
Mitrou, P.S.2
Merkle, K.3
Herold, M.4
Assmann, M.5
Wilhelm, G.6
Dachselt, K.7
Richter, P.8
Schirmer, V.9
Schulze, A.10
Subert, R.11
Harksel, B.12
Grobe, N.13
Stelzer, E.14
Schulze, M.15
Bittrich, A.16
Freund, M.17
Pasold, R.18
Friedrich, T.19
Helbig, W.20
Niederwieser, D.21
more..
-
23
-
-
0022372504
-
The pharmacokinetics of bendamustine (Cytostasane) in humans
-
Preiss R, Sohr R, Matthias M, Brockmann B, Huller H (1985) The pharmacokinetics of bendamustine (Cytostasane) in humans. Pharmazie 40:782-784
-
(1985)
Pharmazie
, vol.40
, pp. 782-784
-
-
Preiss, R.1
Sohr, R.2
Matthias, M.3
Brockmann, B.4
Huller, H.5
-
24
-
-
0037224796
-
Effects of amifostine on clonogenic mesenchymal progenitors and hematopoietic progenitors exposed to radiation
-
Ramdas J, Warrier RP, Scher C, Larussa V (2003) Effects of amifostine on clonogenic mesenchymal progenitors and hematopoietic progenitors exposed to radiation. J Pediatr Hematol Oncol 25:19-26
-
(2003)
J Pediatr Hematol Oncol
, vol.25
, pp. 19-26
-
-
Ramdas, J.1
Warrier, R.P.2
Scher, C.3
Larussa, V.4
-
25
-
-
34249795785
-
A phase i study of bendamustine hydrochloride administered day 1 + 2 every 3 weeks in patients with solid tumours
-
Rasschaert M, Schrijvers D, Van den Brande J, Dyck J, Bosmans J, Merkle K, Vermorken JB (2007) A phase I study of bendamustine hydrochloride administered day 1 + 2 every 3 weeks in patients with solid tumours. Br J Cancer 96:1692-1698
-
(2007)
Br J Cancer
, vol.96
, pp. 1692-1698
-
-
Rasschaert, M.1
Schrijvers, D.2
Van Den Brande, J.3
Dyck, J.4
Bosmans, J.5
Merkle, K.6
Vermorken, J.B.7
-
26
-
-
0038277105
-
Tumor cell senescence in cancer treatment
-
Roninson IB (2003) Tumor cell senescence in cancer treatment. Cancer Res 63:2705-2715
-
(2003)
Cancer Res
, vol.63
, pp. 2705-2715
-
-
Roninson, I.B.1
-
27
-
-
0036340530
-
In vitro studies with bendamustine: Enhanced activity in combination with rituximab
-
Rummel MJ, Chow KU, Hoelzer D, Mitrou PS, Weidmann E (2002) In vitro studies with bendamustine: enhanced activity in combination with rituximab. Semin Oncol 29:12-14
-
(2002)
Semin Oncol
, vol.29
, pp. 12-14
-
-
Rummel, M.J.1
Chow, K.U.2
Hoelzer, D.3
Mitrou, P.S.4
Weidmann, E.5
-
28
-
-
33947657465
-
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma
-
Schmidt-Hieber M, Blau IW, Trenschel R, Andreesen R, Stuhler G, Einsele H, Kanz L, Keilholz U, Marinets O, Beelen DW, Fauser AA, Volin L, Ruutu T, Uharek L, Fietz T, Knauf W, Hopfenmuller W, Thiel E, Freund M, Casper J (2007) Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma. Bone Marrow Transplant 39:389-396
-
(2007)
Bone Marrow Transplant
, vol.39
, pp. 389-396
-
-
Schmidt-Hieber, M.1
Blau, I.W.2
Trenschel, R.3
Andreesen, R.4
Stuhler, G.5
Einsele, H.6
Kanz, L.7
Keilholz, U.8
Marinets, O.9
Beelen, D.W.10
Fauser, A.A.11
Volin, L.12
Ruutu, T.13
Uharek, L.14
Fietz, T.15
Knauf, W.16
Hopfenmuller, W.17
Thiel, E.18
Freund, M.19
Casper, J.20
more..
-
29
-
-
0036340334
-
Phase i studies with bendamustine: An update
-
Schrijvers D, Vermorken JB (2002) Phase I studies with bendamustine: an update. Semin Oncol 29:15-18
-
(2002)
Semin Oncol
, vol.29
, pp. 15-18
-
-
Schrijvers, D.1
Vermorken, J.B.2
-
30
-
-
0036798734
-
In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia
-
Schwanen C, Hecker T, Hubinger G, Wolfle M, Rittgen W, Bergmann L, Karakas T (2002) In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia. Leukemia 16:2096-2105
-
(2002)
Leukemia
, vol.16
, pp. 2096-2105
-
-
Schwanen, C.1
Hecker, T.2
Hubinger, G.3
Wolfle, M.4
Rittgen, W.5
Bergmann, L.6
Karakas, T.7
-
31
-
-
9144222685
-
Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia
-
Tournilhac O, Cazin B, Leprètre S, Diviné M, Maloum K, Delmer A, Grosbois B, Feugier P, Maloisel F, Villard F, Villemagne B, Bastit D, Belhadj K, Azar N, Michallet M, Manhès G, Travade P (2004) Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. Blood 103:363-365
-
(2004)
Blood
, vol.103
, pp. 363-365
-
-
Tournilhac, O.1
Cazin, B.2
Leprètre, S.3
Diviné, M.4
Maloum, K.5
Delmer, A.6
Grosbois, B.7
Feugier, P.8
Maloisel, F.9
Villard, F.10
Villemagne, B.11
Bastit, D.12
Belhadj, K.13
Azar, N.14
Michallet, M.15
Manhès, G.16
Travade, P.17
-
32
-
-
0038359609
-
Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents
-
Volpe DA, Warren MK (2003) Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents. Toxicol In Vitro 17:271-277
-
(2003)
Toxicol in Vitro
, vol.17
, pp. 271-277
-
-
Volpe, D.A.1
Warren, M.K.2
-
33
-
-
24044442891
-
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): A phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC
-
Von Minckwitz G, Chernozemsky I, Sirakova L, Chilingirov P, Souchon R, Marschner N, Kleeberg U, Tsekov C, Fritze D, Thomssen C, Stuart N, Vermorken JB, Loibl S, Merkle KH, Kaufmann M (2005) Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC. Anticancer Drugs 16:871-877
-
(2005)
Anticancer Drugs
, vol.16
, pp. 871-877
-
-
Von Minckwitz, G.1
Chernozemsky, I.2
Sirakova, L.3
Chilingirov, P.4
Souchon, R.5
Marschner, N.6
Kleeberg, U.7
Tsekov, C.8
Fritze, D.9
Thomssen, C.10
Stuart, N.11
Vermorken, J.B.12
Loibl, S.13
Merkle, K.H.14
Kaufmann, M.15
-
34
-
-
0033953195
-
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma
-
Zinzani PL, Magagnoli M, Moretti L, De Renzo A, Battista R, Zaccaria A, Guardigni L, Mazza P, Marra R, Ronconi F, Lauta VM, Bendandi M, Gherlinzoni F, Gentilini P, Ciccone F, Cellini C, Stefoni V, Ricciuti F, Gobbi M, Tura S (2000) Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma. J Clin Oncol 18:773-779
-
(2000)
J Clin Oncol
, vol.18
, pp. 773-779
-
-
Zinzani, P.L.1
Magagnoli, M.2
Moretti, L.3
De Renzo, A.4
Battista, R.5
Zaccaria, A.6
Guardigni, L.7
Mazza, P.8
Marra, R.9
Ronconi, F.10
Lauta, V.M.11
Bendandi, M.12
Gherlinzoni, F.13
Gentilini, P.14
Ciccone, F.15
Cellini, C.16
Stefoni, V.17
Ricciuti, F.18
Gobbi, M.19
Tura, S.20
more..
|